Skip to main content
. 2023 Jun 5;13:1147604. doi: 10.3389/fonc.2023.1147604

Table 2.

Description of variables in the dataset.

Variable Levels Total
(n=3580)
Status P-value
Censored
(n=3146)
Deceased
(n=434)
Age at diagnosis (years) Mean ± SD 48.83 ± 11.59 48.59 ± 11.30 50.51 ± 13.38 0.005
Education Higher education 1293 (36.12%) 1188 (37.76%) 105 (24.19%) <0.001
Highschool diploma 1327 (37.07%) 1188 (37.76%) 139 (32.03%)
Middle school 402 (11.23%) 333 (10.58%) 69 (15.90%)
Elementary school 353 (9.86%) 288 (9.15%) 65 (14.98%)
Illiterate 205 (5.73%) 149 (4.74%) 56 (12.90%)
Marital status Not married 539 (15.06%) 471 (14.97%) 68 (15.67%) 0.704
Married 3041 (84.94%) 2675 (85.03%) 366 (84.33%)
Gravidity 0 426 (11.90%) 384 (12.21%) 42 (9.68%) <0.001
1-2 1320 (36.87%) 1182 (37.57%) 138 (31.80%)
3-4 1260 (35.20%) 1103 (35.06%) 157 (36.18%)
More than 4 574 (16.03%) 477 (15.16%) 97 (22.35%)
Abortion No 2466 (68.88%) 2163 (68.75%) 303 (69.82%) 0.654
Yes 1114 (31.12%) 983 (31.25%) 131 (30.18%)
Breastfeeding duration 0 585 (16.34%) 529 (16.82%) 56 (12.90%) 0.001
Less than 2 years 1308 (36.54%) 1130 (35.92%) 178 (41.01%)
2-4 years 1396 (38.99%) 1246 (39.61%) 150 (34.56%)
4-6 years 291 (8.13%) 241 (7.66%) 50 (11.52%)
More than 6 years 0 (0.00%) 0 (0.00%) 0 (0.00%)
Family history None 2601 (72.65%) 2283 (72.57%) 318 (73.27%) 0.382
1st degree 514 (14.36%) 460 (14.62%) 54 (12.44%)
2nd degree 465 (12.99%) 403 (12.81%) 62 (14.29%)
Tumor size T1 1077 (30.08%) 1006 (31.98%) 71 (16.36%) <0.001
T2 1640 (45.81%) 1447 (45.99%) 193 (44.47%)
T3 863 (24.11%) 693 (22.03%) 170 (39.17%)
Lymph node status N0 1803 (50.36%) 1678 (53.34%) 125 (28.80%) <0.001
N1 1006 (28.10%) 901 (28.64%) 105 (24.19%)
N2 528 (14.75%) 406 (12.91%) 122 (28.11%)
N3 243 (6.79%) 161 (5.12%) 82 (18.89%)
Tumor stage I 725 (20.25%) 700 (22.25%) 25 (5.76%) <0.001
II 1528 (42.68%) 1416 (45.01%) 112 (25.81%)
III 1160 (32.40%) 944 (30.01%) 216 (49.77%)
IV 167 (4.66%) 86 (2.73%) 81 (18.66%)
Tumor grade Low 362 (10.11%) 333 (10.58%) 29 (6.68%) 0.016
Intermediate 2044 (57.09%) 1799 (57.18%) 245 (56.45%)
High 1174 (32.79%) 1014 (32.23%) 160 (36.87%)
Molecular Subtypes Subgroup 1: ER + or PR +/HER2 + 503 (14.05%) 443 (14.08%) 60 (13.82%) <0.001
Subgroup 2: ER + or PR +/HER2 - 2175 (60.75%) 1961 (62.33%) 214 (49.31%)
Subgroup 3: ER - and PR -/HER2 + 270 (7.54%) 226 (7.18%) 44 (10.14%)
Subgroup 4: ER – and PR -/HER2 – 632 (17.65%) 516 (16.40%) 116 (26.73%)
Pathology Invasive ductal carcinoma 3358 (93.80%) 2943 (93.55%) 415 (95.62%) 0.093
Invasive lobular carcinoma 222 (6.20%) 203 (6.45%) 19 (4.38%)
Lymph vascular invasion No 2426 (67.77%) 2186 (69.49%) 240 (55.30%) <0.001
Yes 1154 (32.23%) 960 (30.51%) 194 (44.70%)
Type of surgery Breast conserving surgery 2548 (71.17%) 2358 (74.95%) 190 (43.78%) <0.001
Modified radical mastectomy 1032 (28.83%) 788 (25.05%) 244 (56.22%)
Chemotherapy None 472 (13.18%) 452 (14.37%) 20 (4.61%) <0.001
Adjuvant 2586 (72.23%) 2247 (71.42%) 339 (78.11%)
nonadjuvanted 522 (14.58%) 447 (14.21%) 75 (17.28%)
Radiotherapy None 137 (3.83%) 115 (3.66%) 22 (5.07%) <0.001
External 2937 (82.04%) 2533 (80.51%) 404 (93.09%)
Intraoperative 506 (14.13%) 498 (15.83%) 8 (1.84%)
Hormonotherapy No 714 (19.94%) 600 (19.07%) 114 (26.27%) <0.001
Yes 2866 (80.06%) 2546 (80.93%) 320 (73.73%)

The frequency (percentage) was used to describe the categorical data. Numeric variables were presented using mean ± SD. The association between status (censored and deceased) and categorical variables was evaluated using Pearson Chi-Square test. The independent test was used to compare the mean of age between groups.